Lactobacillus acidophilus BCMC® 12130, Lactobacillus casei BCMC® 12313, Lactobacillus lactis BCMC® 12451, Bifidobacterium bifidum BCMC® 02290, Bifidobacterium infantis BCMC® 02129, Bifidobacterium longum BCMC® 02120.
Adult 3 g: Cream coloured granular powder.
Each sachet (3 g) contains: Lactobacillus acidophilus BCMC® 12130 107 mg, Lactobacillus casei BCMC® 12313 107 mg, Lactobacillus lactis BCMC® 12451 107 mg, Bifidobacterium bifidum BCMC® 02290 107 mg, Bifidobacterium longum BCMC® 02120 107 mg, Bifidobacterium infantis BCMC® 02129 107 mg.
Children 1.5 g: Cream coloured granular powder.
Each sachet (1.5 g) contains: Lactobacillus acidophilus BCMC® 12130 53.5 mg, Lactobacillus casei BCMC® 12313 53.5 mg, Lactobacillus lactis BCMC® 12451 53.5 mg, Bifidobacterium bifidum BCMC® 02290 53.5 mg, Bifidobacterium longum BCMC® 02120 53.5 mg, Bifidobacterium infantis BCMC® 02129 53.5 mg.
Disruption of normal gastrointestinal (GI) function is a common consequence from many aspects of our modern lifestyle such as high stress levels, alcohol consumption, illnesses, surgery, infection and medications. Recent clinical studies indicate HEXBIO plays a critical role in improving stool frequency and stool consistency in chronic constipation, promotes faster return and recovery of gut function after abdominal surgery, aids in glycaemic control in people with type-2 diabetes, has the potential to improve renal profile and liver function in humans, improve glucose metabolism in post-GDM women, and reduce NSAIDS consumption and improve mental health in primary dysmenorrhea. HEXBIO supplies an abundance of strain-specific Microbial Cell Preparation (MCP) that stabilizes the intestinal barrier, stimulates cellular growth, activates mucus production, gut motility, and enhances overall immunity. HEXBIO is therefore, widely used to restore and maintain overall GI health. Common health conditions includes constipation, diarrhoea (AGE, AAD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastro-esophageal reflux (GERD), dyspepsia, urinary tract infection and dysmenorrhea.
Pharmacology: Pharmacodynamics: HEXBIO is a Microbial Cell Preparation (MCP) containing a unique formulation of six strain-specific microorganism (6) (Lactobacillus acidophilus BCMC® 12130, Lactobacillus casei BCMC® 12313, Lactobacillus lactis BCMC® 12451, Bifidobacterium bifidum BCMC® 02290, Bifidobacterium infantis BCMC® 02129, and Bifidobacterium longum BCMC® 02120). These MCP-6 are a ubiquitous component of the normal gastrointestinal microbiota and do not have any pathogenic potential. Upon exposure to bile salt in the duodenum of the small intestine, MCP-6 are stimulated to produce Bile Salt Hydrolase (BSH) enzyme. HEXBIO work via their BSH activities, converting bile salts into primary bile acids. Primary bile acids play a fundamental role in increasing water secretion into the colon, thus stimulating gut motility. These MCP-6 also have inherent antibacterial and anti-inflammatory properties, inhibiting the growth of pathogenic bacteria and viruses, resulting in increased immunity. Coupled with their high gastrointestinal acid and bile tolerance, BSH activity and enhanced defence mechanism in the gastrointestinal tract, the specific Lactobacillus spp. and Bifidobacterium spp. strains of HEXBIO can lower the pH level of the colon (optimum acidic environment), enhance peristalsis, reduce colonic transit time, and contribute to the overall recovery and restoration of balance of the intestinal microbiota.
Pharmacokinetics: No signs of liver toxicity has been reported with the administration of HEXBIO MCP Granule. This product has a fast onset of action which improves symptoms shortly after consumption. All the MCP-6 in HEXBIO have been proven to be gastric acid resistant and bile salt resistant, thus able to survive via intestinal tract transit. This was demonstrated in a human clinical trial whereby a significantly increased strains of Bifidobacterium spp. and Lactobacillus spp. were detected in the faecal samples of subjects given HEXBIO compared to placebo group.
HEXBIO is a uniquely formulated probiotic to improve GI health.
Adults 3 g: 1 sachet twice daily.
Children (1 - 12 years old) 1.5 g: 1 sachet twice daily.
Method of Administration: Can be taken before or after meal.
Oral consumption: Pour the content directly into the mouth. Drink water if needed.
Oral suspension: Dissolve the content in room temperature water or beverage before consumption.
Tube feeding: Mix the content with 5 ml of water and pour the mixture down the feeding tube. Wash the feeding tube with 5-10 ml of water.
There are no clinical findings of overdose reported.
There are no known contraindications reported.
This product can be consumed during pregnancy and lactation based on the advice of a physician.
There are no known medicinal interactions succeeding to the administration of other drugs.
Store at temperatures below 25°C.
Protect from direct sunlight and moisture.
Shelf-Life: Expiry 2 years from the manufacturing date as indicated on the outer package. However, once sachet is open, product has to be administered immediately to avoid contamination and undesirable effects.
A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS ; Used in treatment of alimentary tract and metabolism problems.
A16AX - Various alimentary tract and metabolism products ; Used in treatment of alimentary tract and metabolism problems.
Hexbio Original adult granules 3 g
((original flavour)) 20 × 1's
Hexbio Original childn granules 1.5 g
((original flavour)) 20 × 1's
Sign Out
